Related references
Note: Only part of the references are listed.Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis
Toshiharu Sakurai et al.
MOLECULAR ONCOLOGY (2022)
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody Smith et al.
NATURE MEDICINE (2022)
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee et al.
NATURE MEDICINE (2022)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman et al.
NATURE MEDICINE (2022)
Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis
Julia Fritsch et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study
Andreas Zollner et al.
JOURNAL OF CROHNS & COLITIS (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer et al.
SCIENCE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
Pedro Pinto-Lopes et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Biomarkers for assessment of intestinal permeability in clinical practice
Benjamin Seethaler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)
Calprotectin: from biomarker to biological function
Almina Jukic et al.
GUT (2021)
Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8+T cells and an infiltration pattern that resembles ulcerative colitis
Sara Hone Lopez et al.
VIRCHOWS ARCHIV (2021)
The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease
Alexa N. Sasson et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
Tessa Straatmijer et al.
JOURNAL OF CROHNS & COLITIS (2021)
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Andrea Botticelli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease
Azucena Salas et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Increased Intestinal Permeability Is Associated With Later Development of Crohn 's Disease
Williams Turpin et al.
GASTROENTEROLOGY (2020)
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Adrienne M. Luoma et al.
CELL (2020)
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
Motoo Nomura et al.
JAMA NETWORK OPEN (2020)
Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia on Confocal Laser Endomicroscopy and Ex Vivo Mucosa Analysis
Borko Nojkov et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
Ilaria Grazia Zizzari et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Duodenal and Rectal Mucosa Inflammation in Patients With Non-celiac Wheat Sensitivity
Antonio Carroccio et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Modulating the microbiome to improve therapeutic response in cancer
Jennifer L. McQuade et al.
LANCET ONCOLOGY (2019)
Leaky gut: mechanisms, measurement and clinical implications in humans
Michael Camilleri
GUT (2019)
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small updates cell lung cancer patients treated with nivolumab
Julia Ouaknine Krief et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses
Katerina Pantavou et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome
Qiqi Zhou et al.
GUT (2019)
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease
Sebastian Zeissig et al.
GUT (2019)
Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels
Rosica Valcheva et al.
GUT MICROBES (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis
T. Gambichler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis
Konstantinos C. Fragkos et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease
Thomas Hueso et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
Haruhiko Ogata et al.
INTESTINAL RESEARCH (2018)
Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing
Jeff Chang et al.
GASTROENTEROLOGY (2017)
Regionalized Development and Maintenance of the Intestinal Adaptive Immune Landscape
William W. Agace et al.
IMMUNITY (2017)
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
Neeraj Narula et al.
INFLAMMATORY BOWEL DISEASES (2017)
Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease
Silje Thorsvik et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Human small intestine is capable of restoring barrier function after short ischemic periods
Dirk H. S. M. Schellekens et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
Karen Dubois-Camacho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients
Hongxiang Li et al.
BMC GASTROENTEROLOGY (2017)
Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis
G. D'Haens
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission
Francesca Palone et al.
INFLAMMATORY BOWEL DISEASES (2016)
MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis
Keiichi Haga et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial
Daniel A. Leffler et al.
GASTROENTEROLOGY (2015)
Towards a more comprehensive concept for prebiotics
Laure B. Bindels et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
The Role of Thiopurines in Reducing the Need for Surgical Resection in Crohn's Disease: A Systematic Review and Meta-Analysis
Sukhdev Chatu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Intestinal permeability - a new target for disease prevention and therapy
Stephan C. Bischoff et al.
BMC GASTROENTEROLOGY (2014)
Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis
Houssam E. Mardini et al.
INFLAMMATORY BOWEL DISEASES (2014)
Safety and Activity of Dersalazine Sodium in Patients with Mild-to-moderate Active Colitis: Double-blind Randomized Proof of Concept Study
Caridad Pontes et al.
INFLAMMATORY BOWEL DISEASES (2014)
Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection A Systematic Review
Giovanni Cammarota et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
Ruben J. Colman et al.
JOURNAL OF CROHNS & COLITIS (2014)
Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies
M. P. M. Adriaanse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria
M. J. Barnes et al.
MUCOSAL IMMUNOLOGY (2013)
Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis
Suresh Pola et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease
Rainer Noth et al.
JOURNAL OF CROHNS & COLITIS (2012)
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment
T. L. Mikhailova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease
T. Aomatsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
Anssi Hamalainen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX®) for active left-sided ulcerative colitis
G. Celasco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers
Shilpa Joshi et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Increased Number and Activation of Colonic Macrophages in Pediatric Patients with Untreated Crohn's Disease
Gori Perminow et al.
INFLAMMATORY BOWEL DISEASES (2009)
A Pilot Study on the Noninvasive Evaluation of Intestinal Damage in Celiac Disease Using I-FABP and L-FABP
Joep P. M. Derikx et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome
J. Zeng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Allergy and the gastrointestinal system
G. Vighi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Carotenoids, Retinol, and Intestinal Barrier Function in Children From Northeastern Brazil
Milena M. Vieira et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
T. Kaiser et al.
GUT (2007)
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes
Simon P. Dunlop et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
New lessons: classic treatments, expanding options in ulcerative colitis
SB Hanauer
COLORECTAL DISEASE (2006)
Functional CD4(+)CD25(high) regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
Nathalie Holmen et al.
INFLAMMATORY BOWEL DISEASES (2006)
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis
G Van Assche et al.
GASTROENTEROLOGY (2003)
Share Paper
